Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.76 USD | +2.86% | -1.07% | -17.77% |
Financials (USD)
Sales 2024 * | 99.85M | Sales 2025 * | 253M | Capitalization | 727M |
---|---|---|---|---|---|
Net income 2024 * | -231M | Net income 2025 * | -96M | EV / Sales 2024 * | 6.26 x |
Net cash position 2024 * | 102M | Net cash position 2025 * | 157M | EV / Sales 2025 * | 2.25 x |
P/E ratio 2024 * |
-2.98
x | P/E ratio 2025 * |
-8.42
x | Employees | 344 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.85% |
Latest transcript on REGENXBIO Inc.
1 day | +2.86% | ||
1 week | -1.07% | ||
Current month | +2.86% | ||
1 month | -12.30% | ||
3 months | -30.34% | ||
6 months | -24.96% | ||
Current year | -17.77% |
Managers | Title | Age | Since |
---|---|---|---|
Kenneth Mills
FOU | Founder | 49 | 08-07-15 |
Vit Vasista
DFI | Director of Finance/CFO | 56 | 09-07-31 |
Chief Tech/Sci/R&D Officer | - | 15-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 21-09-02 |
David Stump
BRD | Director/Board Member | 74 | 15-10-14 |
Director/Board Member | 71 | 15-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.76% | 14 M€ | -5.04% | ||
0.25% | 25 M€ | -2.76% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 14.76 | +2.86% | 355,505 |
24-05-31 | 14.35 | 0.00% | 424,738 |
24-05-30 | 14.35 | +1.70% | 582,425 |
24-05-29 | 14.11 | -5.68% | 328,943 |
Delayed Quote Nasdaq, June 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.77% | 727M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.75% | 22.48B | |
-9.35% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- RGNX Stock